“…The structures of 119 ERb inhibitors and activators (1-119, Table A and Figure A in Supporting Information) were collected from recently published literature [2,3,6,8,9,11,16,17,[39][40][41][42][43][44][45][46][47][48][49][50][51][52][53][54][55]86]. Although the collected ERb ligands were gathered from different articles and were bioassayed employing two in vitro methodologies, it was possible to normalize their ERb affinities based on the fact that compound 48 and estradiol were bioassayed by the two methods.…”